Profile | GDS4284 / 212107_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1088.19 | 75 |
GSM687648 | Patient 402 control | 585.174 | 66 |
GSM687653 | Patient 403 control | 1387.42 | 79 |
GSM687658 | Patient 404 control | 615.179 | 67 |
GSM687663 | Patient 411 control | 1107.12 | 75 |
GSM687668 | Patient 422 control | 1319.79 | 78 |
GSM687673 | Patient 424 control | 1178.82 | 76 |
GSM687678 | Patient 425 control | 797.197 | 70 |
GSM687683 | Patient 427 control | 787.377 | 70 |
GSM687688 | Patient 428 control | 842.884 | 71 |
GSM687695 | Patient 441 control | 249.879 | 44 |
GSM687699 | Patient 443 control | 674.536 | 68 |
GSM687704 | Patient 444 control | 802.984 | 71 |
GSM687707 | Patient 448 control | 1452.27 | 80 |
GSM687712 | Patient 449 control | 872.441 | 72 |
GSM687719 | Patient 450 control | 417.121 | 59 |
GSM687724 | Patient 451 control | 1444.88 | 80 |
GSM687728 | Patient 452 control | 1206.45 | 77 |
GSM687646 | Patient 401 treated 24h | 1318.49 | 78 |
GSM687649 | Patient 402 treated 24h | 985.793 | 73 |
GSM687665 | Patient 411 treated 24h | 661.57 | 67 |
GSM687651 | Patient 402 treated 4 weeks | 1040.88 | 74 |
GSM687667 | Patient 411 treated 4 weeks | 1494.06 | 80 |
GSM687670 | Patient 422 treated 24h | 1508.87 | 80 |
GSM687671 | Patient 422 treated 4 weeks | 1981.9 | 83 |
GSM687654 | Patient 403 treated 24h | 1147.74 | 76 |
GSM687675 | Patient 424 treated 24h | 1426.89 | 79 |
GSM687685 | Patient 427 treated 24h | 1098.09 | 75 |
GSM687656 | Patient 403 treated 4 weeks | 1817.4 | 82 |
GSM687677 | Patient 424 treated 4 weeks | 726.307 | 69 |
GSM687687 | Patient 427 treated 4 weeks | 1776.76 | 82 |
GSM687692 | Patient 428 treated 4h | 542.954 | 65 |
GSM687716 | Patient 449 treated 4h | 673.984 | 68 |
GSM687722 | Patient 450 treated 4h | 285.529 | 52 |
GSM687680 | Patient 425 treated 24h | 702.429 | 68 |
GSM687690 | Patient 428 treated 24h | 496.101 | 64 |
GSM687700 | Patient 443 treated 24h | 450.782 | 59 |
GSM687705 | Patient 444 treated 24h | 715.973 | 69 |
GSM687714 | Patient 449 treated 24h | 613.317 | 67 |
GSM687721 | Patient 450 treated 24h | 517.07 | 63 |
GSM687682 | Patient 425 treated 4 weeks | 492.531 | 64 |
GSM687694 | Patient 428 treated 4 weeks | 582.656 | 66 |
GSM687702 | Patient 443 treated 4 weeks | 864.718 | 71 |
GSM687718 | Patient 449 treated 4 weeks | 475.165 | 63 |
GSM687723 | Patient 450 treated 4 weeks | 356.398 | 58 |
GSM687661 | Patient 404 treated 4h | 324.621 | 56 |
GSM687710 | Patient 448 treated 4h | 1539.66 | 81 |
GSM687726 | Patient 451 treated 4h | 1380.43 | 79 |
GSM687730 | Patient 452 treated 4h | 224.352 | 35 |
GSM687660 | Patient 404 treated 24h | 283.467 | 52 |
GSM687697 | Patient 441 treated 24h | 740.124 | 69 |
GSM687709 | Patient 448 treated 24h | 1501.13 | 80 |
GSM687725 | Patient 451 treated 24h | 1077.1 | 75 |
GSM687729 | Patient 452 treated 24h | 975.457 | 76 |
GSM687727 | Patient 451 treated 4 weeks | 1413.07 | 79 |
GSM687731 | Patient 452 treated 4 weeks | 990.71 | 74 |